Table of Contents
Overview
Definition of Translational Medicine
Translational medicine (TM) is a branch of medical research focused on improving human health and longevity by facilitating a faster, easier, and less expensive transition from preclinical research to clinical applications that can effectively address human diseases. This field aims to determine the relevance of novel discoveries in the biological sciences to human disease and seeks to coordinate the application of new knowledge in clinical practice. Additionally, translational medicine incorporates clinical observations and questions into scientific hypotheses in the laboratory, thereby fulfilling the social value of science by producing useful products that enhance people's lives.[5.1] Emerging as a new paradigm in the late 20th century, translational medicine focuses on accelerating the transfer of knowledge generated in laboratory settings (bench) to clinical practice (bedside), ultimately benefiting the broader community.[8.1] It encompasses a spectrum of activities, including the integration of biomarkers, personalized medicine, big data, and artificial intelligence, all aimed at improving patient outcomes and streamlining drug development processes.[3.1] Translational medicine is a highly interdisciplinary field aimed at significantly improving the global healthcare system by integrating various scientific and clinical expertise.[6.1] This discipline is characterized by its fundamental vision to efficiently and effectively translate basic scientific findings relevant to human disease into knowledge that benefits patients.[9.1] The process of translational research involves linking basic scientific discoveries with clinical investigations and translating the results of clinical trials into changes in clinical practice and health care policy, thereby addressing public health problems.[7.1] Although the term "translational medicine" was introduced in the 1990s, it gained widespread usage in the early 2000s, emerging from the bench-to-bedside concept, which seeks to eliminate barriers between laboratory research and clinical application.[8.1]Importance in Healthcare
Translational medicine plays a critical role in advancing healthcare by bridging the gap between laboratory discoveries and clinical practice. This field is essential for translating scientific breakthroughs into practical interventions that benefit patients and society, thereby enhancing health outcomes and improving patient care.[18.1] The integration of patient and public involvement in clinical research is increasingly recognized as a paradigm shift that enhances the relevance and effectiveness of studies aimed at addressing unmet medical needs.[16.1] Engaging patients early in the research process allows for the design of clinical trials that are more aligned with patient priorities, ultimately leading to more meaningful research questions and efficient use of resources.[17.1] Translational research is essential in advancing medical science as it bridges the gap between laboratory discoveries and clinical practice. This research encompasses a broad continuum that includes basic science, clinical research, and epidemiological studies, all aimed at developing practical clinical applications.[22.1] Integrating patient partners into study teams is crucial, as it accelerates innovation and enhances the relevance of research findings, ultimately leading to improved health outcomes.[19.1] Several success stories illustrate the impact of translational medicine on patient care, with the development of targeted therapies for cancer, such as tyrosine kinase inhibitors and monoclonal antibodies, serving as prime examples of how laboratory discoveries can directly influence clinical practices.[23.1] Despite the challenges faced in the journey from bench to bedside, the successes achieved in translational research underscore its significance in enhancing patient care and outcomes.[24.1] The integration of advanced analytics, including big data and artificial intelligence, is transforming traditional pathways of drug development within translational medicine. These technologies enable researchers to exploit vast datasets, such as genomic and proteomic information, thereby enhancing decision-making processes across various fields of biomedical research.[27.1] As a result, translational medicine not only facilitates the translation of laboratory discoveries into clinical applications but also fosters a more sustainable and efficient healthcare system.In this section:
History
Early Concepts and Development
The concept of translational medicine has its roots in the mid-19th century, a period marked by significant medical breakthroughs that laid the groundwork for modern healthcare practices. Key discoveries during this time, such as the development of anesthesia, germ theory, and advancements in surgical techniques, played a pivotal role in transforming patient care and shaping the trajectory of medical research. For instance, the introduction of ether as an anesthetic by William T.G. Morton in 1846 revolutionized surgical procedures by alleviating pain, thus marking the beginning of painless surgery, which is considered one of the most significant advances in medicine.[65.1] The concept of translational medicine was first introduced by Geraghty in 1996, although its origins can be traced back to the mid-19th century when significant scientific breakthroughs in basic research began to emerge.[50.1] The term gained wider usage in the 1990s and became more prominent in the early 2000s, evolving from the "bench-to-bedside" paradigm, which aimed to eliminate barriers between laboratory and clinical research.[51.1] This evolution was further supported by the establishment of the National Center for Advancing Translational Science in December 2011, which was created to transform the translational science process and expedite the delivery of new treatments and cures to patients.[53.1] Additionally, the Clinical and Translational Science Awards, initiated in 2006, have supported numerous centers across the United States, providing essential resources for translational research.[53.1] Despite the advancements in translational medicine, challenges remain, particularly in the allocation of research funding. A significant portion of medical research funding continues to be directed towards basic research rather than health services and public health research, which are crucial for effective translation of scientific findings into clinical practice.[77.1] This imbalance highlights the ongoing need for a more integrated approach that connects basic research with practical applications in healthcare.Formal Introduction and Evolution
Translational medicine has undergone a transformative evolution, increasingly focusing on patient-centric approaches that integrate patient perspectives into research design and prioritize interventions aligned with patient values. This shift enhances the relevance and effectiveness of medical research by actively involving patients as partners in the research process.[59.1] The foundational understanding of translational research was articulated by the Institute of Medicine Clinical Research Roundtable in 2003, which described it as a two-phase process that converts scientific discoveries into clinical applications to improve human health by reducing disease incidence, morbidity, and mortality.[75.1] This framework has been pivotal in bridging the gap between basic research and clinical application. Collaboration between clinical and basic scientists is a cornerstone of translational research. Notable initiatives, such as the interdisciplinary project launched in 2007 to study the human skin microbiota, highlight the potential of collaborative efforts.[62.1] Programs like the Translational Research in Progress (TRIP) seminars further exemplify this by fostering interactions among diverse researchers to present ongoing projects and receive feedback.[61.1] Public-private partnerships (PPPs) have significantly contributed to the evolution of translational medicine. The US Food and Drug Administration's Critical Path Initiative, established in 2004, aimed to modernize drug development through PPPs, promoting data sharing and collaboration between academia and industry.[81.1] These partnerships address challenges in drug development, such as integrating academic research into industry strategies and standardizing regulatory science methods.[81.1] The Center for Translational Molecular Medicine (CTMM) in the Netherlands serves as a model for successful PPPs, focusing on accelerating molecular diagnostics and personalized medicine.[78.1] This model has influenced broader European initiatives like EATRIS, which aim to enhance translational research across Europe.[79.1] The emphasis on collaboration among diverse stakeholders is crucial for achieving the goals of translational medicine, fostering a continuous exchange of ideas and resources necessary for successful outcomes.[80.1]Recent Advancements
Technological Innovations
Recent advancements in translational medicine have been significantly shaped by the development of the CRISPR-Cas9 technology, which is recognized for its adaptability in this field. The CRISPR-Cas9 system is particularly valuable as it facilitates the alteration of genomic sequences, a crucial requirement in translational medicine.[92.1] A review of the latest achievements in CRISPR-Cas9 technology highlights its potential to drive advances in translational medicine, focusing on both pre-clinical and clinical research.[88.1] The principles and characterization of the CRISPR-Cas9 system are also essential components of this discussion, underscoring its foundational role in the ongoing evolution of therapeutic strategies.[92.1] In December 2023, the U.S. Food and Drug Administration (FDA) approved the world's first CRISPR/Cas9 gene-editing therapy, representing a significant advancement in the field of translational medicine.[90.1] This approval highlights the interdisciplinary nature of translational medicine, which aims to bridge the gap between laboratory discoveries and clinical applications, ultimately improving patient outcomes.[91.1] Recent research has demonstrated the potential of CRISPR-based treatments, particularly in a clinical trial targeting the BCL11A gene in patients with sickle cell disease. This trial effectively increased fetal hemoglobin levels and reduced disease symptoms, showcasing the practical applications of gene editing in treating genetic disorders.[89.1] As scientific advancements continue to shape the future of medicine, the integration of innovative technologies like CRISPR is expected to play a crucial role in developing new diagnostic tools and therapies.[90.1] The versatility of CRISPR-Cas9 extends to cancer therapy, where it is utilized to develop personalized treatments that can selectively activate or deactivate genes within tumor cells. This capability aims to inhibit tumor growth and enhance the effectiveness of existing therapies, such as chemotherapy and immunotherapy.[96.1] Additionally, CRISPR technology has been instrumental in engineering CAR-T cells, which are genetically modified to target and eliminate cancer cells with high specificity.[97.1] These advancements illustrate the profound impact of CRISPR-Cas9 on the landscape of translational medicine, providing new avenues for treatment and improving the precision of therapeutic interventions.[95.1] Moreover, the regulatory landscape surrounding translational medicine plays a crucial role in shaping the pace of innovation. Regulatory agencies, including the FDA and the European Medicines Agency (EMA), enforce stringent guidelines to ensure that new therapies meet high standards of safety and efficacy before they are made available to patients.[99.1] This regulatory framework is essential for balancing the rapid advancements in technology with the imperative of patient safety, thereby fostering an environment conducive to innovation in translational medicine.Emerging Therapeutics
Recent advancements in translational medicine have significantly influenced the development of emerging therapeutics, particularly through the application of CRISPR-Cas9 technology. This gene-editing tool has rapidly advanced to human clinical trials across multiple disease areas within less than a decade since its inception, showcasing its potential to revolutionize treatment options in precision medicine.[107.1] The CRISPR-Cas9 system is characterized by its programmability and precision, making it an accessible tool for biomedical research and clinical applications.[106.1] The CRISPR-Cas9 system has seen significant advancements, particularly with the development of dead Cas9 (dCas9), which is a catalytically inactive form of the Cas9 nuclease. This variant can be fused with transcription factors, fluorescent marker proteins, and other functional proteins, allowing for the regulation of gene expression, tracking of target genes, and making unexpected genomic alterations without inducing double-strand breaks (DSBs).[105.1] Furthermore, the fusion of a deaminase to dCas9 has led to the creation of a novel base-editing technology, enabling precise and highly efficient C-to-T or G-to-A modifications.[105.1] Additionally, the introduction of dead guide RNA (dgRNA), characterized by a short 14- to 15-nucleotide sequence with MS2-binding loops, can activate transcription while avoiding DSBs.[105.1] These innovations, including the development of double-nickase Cas9, which generates staggered single cleavages in the genome, significantly reduce off-target effects and expand the translational applications of CRISPR-Cas9 technology.[105.1] Gene therapy, as a broader category, is emerging as a powerful approach to modulate abnormal gene expression, particularly in central nervous system (CNS) disorders. Recent approvals of gene therapies for conditions such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) underscore the transformative potential of this approach.[108.1] Furthermore, the integration of genomic information into clinical decision-making has been shown to improve patient outcomes and facilitate personalized treatment strategies, particularly for rare genetic disorders.[111.1] However, the rapid development of gene therapies also presents regulatory challenges. The expedited approval designations by the FDA for many gene therapies necessitate new validation strategies and active communication with regulatory bodies to ensure safety and efficacy.[113.1] Moreover, the complexity of advanced therapy medicinal products (ATMPs) often requires compliance with more stringent post-approval commitments, which can impact market performance and access to these innovative treatments.[115.1]Challenges In Translational Medicine
Obstacles to Effective Translation
Translational medicine faces several significant obstacles that hinder the effective translation of research findings into clinical practice. One of the primary challenges is the difficulty in translating basic science discoveries into clinical studies. This initial step is crucial, as it sets the foundation for subsequent phases of research and application.[149.1] Following this, the translation of clinical studies into actual medical practice and health care policy presents another major hurdle, complicating the pathway from research to real-world application.[149.1] Regulatory challenges also play a critical role in obstructing the translational process. Accurately predicting human health risks associated with new products based on preclinical data remains an imperfect science, particularly for novel biomaterials and technologies.[148.1] This uncertainty can lead to delays and increased costs in the development and approval of new interventions. Furthermore, the iterative nature of translational research, which involves a continuous feedback loop between laboratory discoveries and clinical applications, can create additional complexities. While this model is designed to foster innovation, it often results in a gap between the knowledge generated and its actual implementation in clinical settings.[132.1] The need for multidisciplinary collaboration among various stakeholders—including clinicians, researchers, and regulatory bodies—is essential to bridge this gap and enhance the efficiency of the translational process.[133.1] Translational medicine faces several significant obstacles that hinder the effective translation of research findings into clinical practice. According to the National Center for Advancing Translational Science, the process of translation involves turning observations from laboratory, clinical, and community settings into interventions that enhance individual and public health.[131.1] There are three major challenges identified in this field: the first is the difficulty in translating basic science discoveries into clinical studies, the second involves the translation of clinical studies into medical practice and healthcare policy, and the third is a philosophical obstacle that reflects differing priorities and perspectives among stakeholders.[149.1] To address these challenges, it is essential for stakeholders to collaborate effectively, improve communication, and leverage advancements in areas such as biomarkers to promote precision medicine.[131.1] Furthermore, the field of dissemination and implementation (D&I) science is crucial for understanding the principles and practices necessary for successful intervention adoption in clinical and public health settings, highlighting the need for multidisciplinary collaboration and innovative strategies within translational science.[134.1]Addressing the Translation Blocks
Translational medicine faces several significant challenges that hinder the effective translation of scientific discoveries into clinical practice. One of the primary obstacles is the need for continuous feedback from clinical practice to refine and improve the translational process. This iterative approach is crucial for assessing the real-world impact of treatments on patient health and for making necessary adjustments based on clinical feedback and outcomes.[153.1] The integration of patients into research not only enhances the relevance of translational medicine in clinical settings but also increases the likelihood of successful implementation of new therapies.[154.1] Interdisciplinary collaboration plays a vital role in overcoming these challenges. By fostering partnerships between academia and industry, translational medicine can benefit from diverse expertise and resources. For instance, the Clinical and Translational Science Awards (CTSA) initiative, launched by the NIH in 2006, aims to enhance the efficiency of translating scientific discoveries into improved clinical treatments by supporting interdisciplinary teams.[136.1] Such collaborations encourage innovative thinking and new methodologies in studying disorders, which can lead to more effective solutions.[137.1] Public-private partnerships (PPPs) are essential in addressing translation blocks within translational medicine by uniting academic and industry expertise while securing funding from governmental, philanthropic, and charitable sources.[144.1] A prominent example of such a partnership is the Medicines for Malaria Venture, a not-for-profit foundation based in Geneva, which focuses on developing new antimalarials for developing countries through public-private collaboration.[144.1] Another significant initiative is the Innovative Medicines Initiative (IMI), which operates with a budget of €2 billion and represents a collaboration between the European Union and the European Federation of Pharmaceutical Industries and Associations. IMI aims to enhance the competitiveness of the pharmaceutical sector across Europe by fostering collaborative networks among key healthcare stakeholders.[145.1] These partnerships illustrate the critical role of PPPs in advancing translational medicine and addressing pressing health challenges through resource pooling and collaboration.[143.1] Moreover, translational biotechnology has emerged as a key player in addressing these challenges. It encompasses a wide range of applications, including drug discovery, biomarker development for precision medicine, and the use of artificial intelligence for improved diagnosis and treatment outcomes.[156.1] By employing molecular engineering techniques and biological materials, translational biotechnology directly impacts healthcare and enhances the potential for successful therapeutic development.[155.1]In this section:
Interdisciplinary Collaboration
Role of Multidisciplinary Teams
Multidisciplinary teams play a crucial role in the advancement of translational medicine by fostering collaboration across various scientific and medical disciplines. Prof. Michel Goldman highlights that translational medicine encompasses a continuum from basic research to clinical applications, emphasizing the necessity of interdisciplinary collaboration to bridge these areas effectively.[167.1] This collaborative approach is particularly vital in oncology, where initiatives like “Young Oncologist United” aim to enhance cooperation among junior medical professionals from diverse backgrounds, thereby improving patient care and research outcomes.[168.1] Despite the recognized importance of interdisciplinary collaboration, researchers often encounter significant barriers, such as communication challenges and differing terminologies across disciplines. These obstacles hinder the effective engagement in translational research.[169.1] To address these issues, it is essential to develop consolidated frameworks that unify conceptual and methodological approaches, facilitating better collaboration among health sciences researchers.[169.1] Training programs, such as the Masters of Research in Translational Medicine, have been established to prepare a new generation of researchers capable of navigating the complexities of interdisciplinary medical research.[170.1] These programs aim to cultivate skills that enable effective collaboration among scientists from various fields, which is increasingly necessary as the healthcare landscape evolves.[170.1] Interdisciplinary partnerships are also exemplified by initiatives like those at Women’s Health Research at Yale, where diverse academic disciplines come together to tackle health issues specifically affecting women.[171.1] Such partnerships not only enhance research quality but also address pressing health concerns through a multifaceted approach. Furthermore, the concept of 'bench to bedside' translational research underscores the importance of close collaboration between researchers and clinicians in designing clinical trials and testing new therapeutic methods.[172.1] This model exemplifies how multidisciplinary teams can effectively translate research findings into practical applications, ultimately benefiting patient care. Accountable care organizations represent another model of interdisciplinary collaboration, where teams comprising primary care physicians, nursing staff, and specialists work together to improve patient outcomes while managing costs.[173.1] This collaborative framework has been shown to enhance the quality of care provided to patients, demonstrating the effectiveness of multidisciplinary approaches in healthcare. As the field of medicine has evolved, it has encountered significant challenges in effectively translating basic research findings into practical applications within clinical and public health settings. This has led to the emergence of a new interdisciplinary field known as engineering medicine, which integrates various scientific disciplines to address these clinical and public health needs.[174.1] The importance of protecting clinician time for research, particularly in cross-disciplinary collaborations, is widely recognized, and solutions are being proposed to enhance these efforts. Interdisciplinary collaborations are often best supported by planned engagement programs facilitated by established research platforms, such as those funded by the National Institute for Health Research (NIHR).[175.1] For example, the NIHR Surgical MedTech Cooperative in Leeds fosters large-scale collaborations among clinicians, physicists, engineers, industry, and patients to address unmet needs.[175.1] Additionally, the Bragg Centre for Advanced Materials Research promotes novel interdisciplinary approaches to key clinical topics, such as drug targeting and delivery, through a regular program of events.[175.1]Integration of Basic and Clinical Research
Translational medicine serves as a vital bridge between basic research and clinical application, significantly expediting the adoption of innovative healthcare approaches and technologies that have the potential to transform patient care.[185.1] This integration is facilitated through translational research, which focuses on translating scientific discoveries into practical applications that benefit patients and society at large. The primary aim of translational research is to enhance human health by merging basic science with clinical practice.[187.1] Key components of translational science include diverse methodologies, interdisciplinary collaborations, and robust infrastructural support systems that are essential for fostering scientific discovery and innovation. Interdisciplinary research teams, which consist of basic scientists, clinicians, epidemiologists, and biostatisticians, collaborate to tackle complex health challenges that require insights from multiple fields.[186.1] Effective communication and project management are critical in this context, as they ensure coordination among various departments and enhance awareness of project developments.[187.1] Moreover, embedding interdisciplinarity into higher education curricula is crucial for developing competencies in synthesizing and applying knowledge across multiple disciplines. This approach enables students to address problems and devise solutions that would be unattainable through a singular disciplinary perspective.[197.1] Programs that foster interpersonal skills such as communication, conflict management, and leadership further enhance collaboration and innovation among graduate students, positioning them for success in their future careers.[196.1]Future Directions
Trends in Research and Practice
Translational medicine (TM) is increasingly recognized as a vital discipline that bridges the gap between scientific research and clinical practice. This field has evolved significantly, particularly in the 21st century, as its importance has gained traction among medical investigators and practitioners alike.[207.1] One of the most notable trends in translational medicine is the rapid development of medical interventions, exemplified by the swift design and distribution of mRNA vaccines within a year, which was made possible by decades of prior research.[208.1] This showcases the potential of translational approaches to expedite healthcare advancements. The establishment of institutions such as the National Center for Advancing Translational Sciences (NCATS) in the USA reflects a concerted effort to enhance the efficiency of the translational research (TR) process. NCATS aims to address bottlenecks, including regulatory challenges, by fostering multidisciplinary collaboration among bioinformaticians, statisticians, engineers, and clinicians.[209.1] This collaborative model is essential for overcoming barriers in the translation of research findings into clinical applications, as it promotes a more integrated approach to healthcare innovation.[210.1] Furthermore, the integration of patient and public perspectives into the translational medicine pathway is emerging as a critical trend. By incorporating subjective experiential knowledge regarding the medical and psychosocial effects of diseases and treatments, researchers can enhance the relevance of their findings and improve health outcomes.[212.1] Engaging patients in the research process not only accelerates innovation but also ensures that the resulting treatments address the actual needs and concerns of patients.[214.1] Establishing formal communication processes for obtaining patient feedback is a foundational step in this integration, allowing for continuous improvement in research and clinical practices.[217.1] As translational medicine continues to evolve, it serves as a systematic approach to bridging the divide between laboratory research and patient care. This integration not only enhances the relevance of research in clinical settings but also increases the likelihood of successful implementation of new therapies.[216.1] The ongoing focus on patient engagement and multidisciplinary collaboration will likely shape the future landscape of translational medicine, ultimately leading to more personalized and effective healthcare solutions.Policy Implications and Funding Strategies
The landscape of translational research is significantly shaped by evolving regulatory frameworks that prioritize safety, efficacy, and ethical compliance in drug development. Recent modifications to these frameworks aim to foster innovation while ensuring patient safety, reflecting a growing recognition of the need for adaptive regulatory approaches that can accommodate emerging technologies in translational medicine.[226.1] For instance, the European Medicines Agency (EMA) is implementing adaptive pathways, which facilitate early and progressive patient access to new medicines while maintaining rigorous regulatory oversight.[227.1] In the United States, the Food and Drug Administration (FDA) has also introduced draft regulatory guidance concerning the use of artificial intelligence (AI) in supporting regulatory decisions, indicating a shift towards integrating advanced technologies into the regulatory process.[228.1] The application of AI in drug development and clinical practice is becoming increasingly vital, enhancing decision-making across various biomedical research areas, including drug discovery and disease diagnosis.[229.1] Moreover, there is a pressing need to balance innovation with equitable access to new treatments, particularly for underserved populations. A reinvigorated discourse in health economics emphasizes the importance of developing health data infrastructures that reflect the perspectives of patients and families, thereby addressing cost and access in a more integrated manner.[230.1] Legislative efforts have historically aimed to reconcile the dual objectives of ensuring timely access to affordable drugs while promoting drug innovation, as seen in the expedited approval processes for generic drugs.[231.1] To further this balance, recommendations have been made to reorient the health and medicine innovation system towards equity, ensuring that it is responsive to a broader range of users' needs.[232.1] The National Academies of Sciences, Engineering, and Medicine have established a committee to create a framework that aligns the development and use of transformative technologies with ethical and equitable principles, underscoring the importance of governance in innovation.[233.1] Finally, the innovation life cycle can lead to both anticipated and unanticipated patterns of inequity, highlighting the ethical imperative for improved governance in health and medicine innovation. This necessitates a framework that aligns with equity principles, ensuring that advancements in translational medicine benefit all populations.[234.1]References
[3] Translational Medicine | Bridging the Gap Between Bench ... - Epainassist — Here is an overview of the translational research spectrum: Basic Biomedical Research (T0): ... Translational medicine also involves the use of biomarkers, personalized medicine, big data, and AI to improve patient outcomes and reduce the time and cost of drug development. By bringing together scientists and clinicians in a collaborative effort
[5] Translational medicine | Advancing Healthcare & Research | Britannica — translational medicine, area of research that aims to improve human health and longevity by determining the relevance to human disease of novel discoveries in the biological sciences.Translational medicine seeks to coordinate the use of new knowledge in clinical practice and to incorporate clinical observations and questions into scientific hypotheses in the laboratory.
[6] Translational Medicine Definition — Accordingly, translational medicine is a highly interdisciplinary field, the primary goal of which is to coalesce assets of various natures within the individual pillars in order to improve the global healthcare system significantly.
[7] Translational research in medicine - PMC - PubMed Central (PMC) — Translational research in medicine - PMC It is the process which leads from evidence based medicine to sustainable solutions for public health problems. It aims to improve the health and longevity of the world’s populations and depends on developing broad-based teams of scientists and scholars who are able to focus their efforts to link basic scientific discoveries with the arena of clinical investigation, and translating the results of clinical trials into changes in clinical practice, informed by evidence from the social and political sciences. The second hurdle is the translation of clinical studies into medical practice and health care policy. A third obstacle to effective translational medicine is also philosophical. Translational Research: from evidence-based medicine to sustainable solutions for public health problems.
[8] History of Translational Medicine - EUPATI — History of Translational Medicine. The term translational medicine was introduced in the 1990s but only gained wide usage in the early 2000s.Originally, translational medical research emerged from the concept of B2B (bench-to-bedside), as a class of medical research aiming to eliminate the barriers between laboratory and clinical research. In 2003, the Institute of Medicine Clinical Research
[9] 1 - Translational Medicine: Definition, History, and Strategies — What is translational medicine? This discipline, although defined differently by various groups in academia, regulatory institutions, and industry, shares the fundamental vision of translational medicine, which is to efficiently and effectively translate basic scientific findings relevant to human disease into knowledge that benefits patients.
[16] Patient involvement in clinical trials | Communications Medicine - Nature — Patient involvement in clinical trials | Communications Medicine Patient involvement in clinical trials Patient involvement in clinical trials Patients need faster and more innovative research and can contribute significantly to clinical trials that are designed to truly meet their unmet needs and priorities, if they are involved as partners in the research process at an early stage. However, patient involvement in clinical trials regularly takes place too late in the research process, if at all. In view of the fact that patients make themselves available for these clinical trials, research conducted without patient involvement in the design may address less meaningful research questions and waste resources on studies which patients do not want to join2. Patient involvement in clinical trials.
[17] Patient involvement in clinical research: why, when, and how — Patient involvement in clinical research: why, when, and how - PubMed Search in PubMed Patient involvement in clinical research: why, when, and how Patient involvement in clinical research: why, when, and how Search in PubMed Specific measures are proposed to improve patient involvement in 1) setting priorities, 2) study leadership and design, 3) improved access to clinical trials, 4) preparation and oversight of the information provided to participants, 5) post-study evaluation of the patient experience, and 6) the dissemination and application of results. How to engage patients in clinical research? How to engage patients in clinical research? J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Patients’ responsibility to participate in decision making and research. Search in PubMed
[18] PDF — The successful incorporation of patient and public perspectives in the translational medicine pathway could facilitate the translation of scientific breakthroughs into interventions that would benefit patients and society.
[19] 329 Clinician and researcher knowledge, barriers, and facilitators of ... — Discussion/Significance of Impact: Integrating patient partners into study teams accelerates innovation and translational science, increases the relevance of research findings, improves health
[22] Basic, translational, and clinical research - a short reflection — Research in endocrinology, like in all other medical disciplines, covers a broad continuum including basic science, translational and clinical research. Translational research aims at bridging the gap between scientific science, clinical, epidemiological and population studies into practical clinical applications.
[23] PDF — and accelerating the translation of discoveries into clinical applications. Several success stories highlight the impact of translational medicine on patient care. The development of targeted therapies for cancer, such as tyrosine kinase inhibitors and monoclonal antibodies, is a prime example of translational medicine.
[24] PDF — Translational research plays a crucial role in advancing medical science by bridging the gap between laboratory discoveries and clinical practice. While the path from bench to bedside is fraught with challenges, the successes achieved in this field underscore its importance in improving patient care and outcomes.
[27] Tribulations and future opportunities for artificial intelligence in ... — This article reviews AI applications in drug development and clinical practice, making healthcare more sustainable, and highlights concerns and limitations in applying AI. The utilization of AI technologies has become increasingly significant in accelerating various areas of biomedical research, including drug discovery and development, image-based disease diagnosis, and the analysis of large datasets, consequently enhancing decision-making processes across a wide range of fields and disciplines such as drug discovery, molecular biology, imaging, pathology, toxicology, and clinical medicine. The words shown in the left column of the table have increased significantly since the first use of AI in any of the selected fields of medical research, including drug discovery, development, medicinal chemistry, cancer research, PM, etc.
[50] Scope highlights of Annals of Translational Medicine based on a review ... — History of translational medicine. Geraghty first introduced the concept of translational medicine in the Lancet in 1996 . However, the origin of this concept dates back to the mid-19th century when the scientific community began to achieve several scientific breakthroughs in the field of basic research, while the corresponding application to
[51] History of Translational Medicine - EUPATI — History of Translational Medicine. The term translational medicine was introduced in the 1990s but only gained wide usage in the early 2000s.Originally, translational medical research emerged from the concept of B2B (bench-to-bedside), as a class of medical research aiming to eliminate the barriers between laboratory and clinical research. In 2003, the Institute of Medicine Clinical Research
[53] Translational medicine - Wikipedia — In December 2011, The National Center for Advancing Translational Science was established within the National Institutes of Health to "transform the translational science process so that new treatments and cures for disease can be delivered to patients faster." The Clinical and Translational Science Awards, established in 2006, supports 60 centers across the country that provide "academic homes for translational sciences and supporting research resources needed by local and national research communities." According to an article published in 2007 in Science Career Magazine, in 2007 to 2013 the European Commission targeted a majority of its €6 billion budget for health research to further translational medicine. Temple University's College of Public Health offers a Master of Science in Clinical Research and Translational Medicine. The program is jointly offered with the Lewis Katz School of Medicine.
[59] Bridging Bench to Bedside: The Unveiling Landscape of Translational ... — Patient-centric approaches: Empowering individuals: The evolution of translational medicine is increasingly influenced by a shift toward patient-centric approaches. Engaging patients as active partners in the research process, incorporating their perspectives in study design and prioritizing interventions that align with patient values
[61] Team Science & Research Collaboration Resources | CTSI — A collaboration between the Clinical and Translational Science Institute and NYU Langone's Department of Medicine, Translational Research in Progress (TRIP) seminars bring together clinical researchers, basic scientists, and population health researchers to present ongoing research projects to their peers and receive feedback.
[62] Bridging the Translational Research Gap: A Successful Partnership ... — Although basic and clinical scientists have long collaborated, translational research challenges investigators to move beyond the traditional training of both laboratory scientists and clinicians. In 2007, we—a clinical researcher (Kong) and a basic scientist (Segre)—initiated an interdisciplinary project to characterize the human skin microbiota associated with both common and rare skin disorders (Grice et al., 2008, 2009). He implemented the NIH Roadmap with the goal of bringing individuals from critical disparate disciplines into translational research teams (Zerhouni, 2003). Although neither of us had prior experience with a translational research team jointly led by a clinical researcher and a basic scientist, our common enthusiasm propelled us into a high-risk research project that proved to be rewarding and fruitful.
[65] 10 Medical Breakthroughs That Changed the World — Before the discovery of anesthesia in the mid-19th century, surgery was a horrifically painful and traumatic experience. But in 1846, a dentist named William T.G. Morton successfully used ether to anesthetize a patient for surgery. This began the era of painless surgery, one of the most significant advances in the history of medicine.
[75] Role of Translational Research in Medicines R&D: History of ... — Role of Translational Research in Medicines R&D: History of Translational Medicine | EUPATI Open Classroom About Open Classroom EUPATI Fellows Our Impact FAQ Glossary EUPATI Toolbox Patient Engagement Roadmap Accessibility Resources Profile Calendar Home About Accessibility Resources EUPATI Fellows FAQ Learning Catalogue Our Impact Patient Engagement Roadmap Patient Expert Training Programme Toolbox About Collapse Expand About Open Classroom EUPATI Fellows Our Impact FAQ Glossary EUPATI Toolbox Patient Engagement Roadmap Accessibility Resources In 2003, the Institute of Medicine Clinical Research Roundtable described the current terminology and model of translational research as a two-phase process of research, progressing from: ‘Translational medicine transforms scientific discoveries arising from laboratory, clinical or population studies into new clinical tools and applications that improve human health by reducing disease incidence, morbidity and mortality’
[77] Funding research translation: how we got here and what to do next — Despite initiatives to boost translational research, most medical research funding continues to be spent on basic research rather than on health services and public health research, where much of the translation needs to be embedded to effect change. This imbalance has been apparent for at least a quarter of a century in Australia (Figure 1 ).
[78] Multi-Dimensional Impact of the Public-Private Center for Translational ... — One of these organizational innovations has been the Center for Translational Molecular Medicine (CTMM), a multi-million public-private partnership in the Netherlands. The CTMM aims to accelerate molecular diagnostics and imaging technologies to forecast disease susceptibilities in healthy populations and early diagnosis and personalized
[79] Public-private partnerships in translational medicine: concepts and ... — The focus of these partnerships has been on drug development, improved diagnosis and regenerative medicine. The Dutch model of public-private partnership forms the blueprint of a much larger European initiative called EATRIS. This paper will provide practical examples of public-private partnerships initiated to expedite the translation of new
[80] Public-private partnerships in translational medicine: Concepts and ... — Obviously, as translational research deals with bench-to-bed side and bed-to-bench side research, and therefore both basic and applied sciences can be found in academia as well as industry, a continuous exchange of ideas between scientists in academia and industrial R&D groups is essential to realize successful translational medicine .In addition, to increase public-private interactions
[81] Public-private partnerships as driving forces in the quest for ... — In 2004, the US Food and Drug Administration (FDA) introduced the Critical Path Initiative with the intent of modernizing drug development by implementing public-private partnerships (PPP) to share data, expertise, and resources. Keywords: Drug development, Drug efficacy, Drug safety, Pre-competitive research, Knowledge management, Public-private partnership, Data sharing, Regulators, Standards There are several causes of the insufficient productivity of the current drug development process, including but not limited to: the insufficient integration of the results of academic research into the research and development strategy of pharmaceutical companies, the insufficient interest in academic institutions in regulatory science, methods standardization and concrete applications of basic discoveries, the lack of established criteria to define acceptable risk-benefit ratio for drug approval by regulatory authorities, and economic considerations making the development of certain drugs unattractive from an industry standpoint.
[88] Progress and Perspective of CRISPR-Cas9 Technology in Translational ... — 2023 Sep;10(25):e2300195. doi: 10.1002/advs.202300195. ... This review aims to present the latest CRISPR-Cas9 technology achievements and prospect to translational medicine advances. The principle and characterization of the CRISPR-Cas9 system are firstly introduced. ... The authors then focus on recent pre-clinical and clinical research
[89] Articles 2023: New Directions in Biology and Health — Explore key biological and health advancements from 2023, highlighting emerging research trends and their potential impact on science and medicine. Scientific advancements in biology and health are shaping the future of medicine, offering new insights into disease mechanisms and potential treatments. Research published in Nature Cell Biology demonstrates that biomolecular condensates—membraneless organelles formed through liquid-liquid phase separation—play a major role in gene expression, protein degradation, and stress responses. Identifying previously unrecognized cell states offers new targets for precision medicine, transforming disease modeling and therapeutic development. A study in The Lancet showcased a clinical trial where patients with sickle cell disease received CRISPR-based treatment targeting the BCL11A gene, effectively increasing fetal hemoglobin levels and reducing disease symptoms.
[90] Here are some of the biggest medical advances in 2023 - Science News — Here are some of the biggest medical advances in 2023 Skip to content Subscribe todayEvery print subscription comes with full digital access Subscribe now Menu All Topics Health Humans Life Earth Physics Space Magazine Menu All Stories Multimedia Reviews Puzzles Collections Century of Science For Educators Coronavirus Outbreak Newsletters About For Students Our Store SIGN IN Donate Home INDEPENDENT JOURNALISM SINCE 1921 SIGN IN Search Open search Close search Home INDEPENDENT JOURNALISM SINCE 1921 All Topics Earth Agriculture Climate Oceans Environment Humans Anthropology Health & Medicine Archaeology Psychology Life Animals Plants Ecosystems Paleontology Neuroscience Genetics Microbes Physics Materials Science Quantum Physics Particle Physics Space Astronomy Planetary Science Cosmology Tech Computing Artificial Intelligence Chemistry Math Science & Society All Topics Health Humans Humans Anthropology Health & Medicine Archaeology Psychology Recent posts in Humans ---------------------- Health & Medicine A second version of bird flu is infecting cows. Justin Sullivan/Getty Images News Share this: Email Facebook Twitter Pinterest Pocket Reddit Print By Erin Wayman December 14, 2023 at 7:00 am Weight-loss drugs stole much of the spotlight in 2023, but these medical advances treating other conditions are also worthy of attention (SN: 12/13/23). Green light for CRISPR gene editing On December 8, the U.S. Food and Drug Administration approved the world’s first CRISPR/Cas9 gene-editing therapy (SN: 12/8/23). Slowing down Alzheimer’s The Alzheimer’s drug lecanemab (brand name Leqembi) won full FDA approval in July. Birth control, no prescription required In July, the FDA ruled that the oral contraceptive norgestrel, first approved in 1973, be available without a prescription.
[91] Advances in Molecular and Translational Medicine - PMC — Translational medicine is an interdisciplinary field that combines basic research findings with clinical practice to accelerate the development of new diagnostic tools, therapies, and preventive strategies for human diseases [].This approach aims to bridge the gap between laboratory discoveries and their application in clinical settings, with the ultimate goal of improving patient outcomes .
[92] Progress and Perspective of CRISPR‐Cas9 Technology in Translational ... — Accordingly, the CRISPR-Cas9 system is adaptable to translational medicine, which calls for the alteration of genomic sequences. This review aims to present the latest CRISPR-Cas9 technology achievements and prospect to translational medicine advances. The principle and characterization of the CRISPR-Cas9 system are firstly introduced.
[95] Progress and Perspective of CRISPR‐Cas9 Technology in Translational ... — Translational research on CRISPR-Cas9 gene editing technology is rapidly advancing, with numerous clinical trials being conducted. Preclinically, CRISPR-based tools such as knock-in, knock-out, activation, and interference have been developed and demonstrated to have a wide range of applications and powerful treatment effects in various diseases.
[96] Harnessing the evolving CRISPR/Cas9 for precision oncology — Upon cancer therapy, CRISPR/Cas9 is instrumental in developing individual and precise cancer therapies that can selectively activate or deactivate genes within tumor cells, aiming to cripple tumor growth and invasion and sensitize cancer cells to treatments. By targeting genes that confer resistance to chemotherapy, radiotherapy, and immunotherapy, CRISPR/Cas9 can sensitize cancer cells to these treatments, enhancing their efficacy. Afterward, Feng Zhang and his colleagues have successfully adapted CRISPR/Cas9 for gene editing in eukaryotic cells, demonstrating its potential for precise genetic manipulation in complex organisms, including humans since 2013. Wang Z, Li N, Feng K, Chen M, Zhang Y, Liu Y, Yang Q, Nie J, Tang N, Zhang X, et al. Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy.
[97] Advances in CRISPR-Cas technology and its applications: revolutionising ... — | Blood | Hemophilia B | F9 | Corrected F9 gene in iPSCs using CRISPR-Cas9; restored F9 expression in hepatocyte-like cells | Morishige et al. One prominent application of CRISPR-Cas9 technology is its application in engineering T-cells express CARs. CAR-T cell therapy is a genetically modified T-cell that expresses CARs, targeting tumour-associated antigens (TAAs) or tumour-specific antigens (TSAs) with high specificity, thereby targeting and eliminating cancer cells (Jogalekar et al., 2022). CRISPR-Cas9 technology has enhanced CAR-T therapy by enabling precise genetic edits that improve T cell functionality, persistence, and specificity (Dimitri et al., 2022). CRISPR-Cas gene editing is utilised to introduce oncolytic viruses with therapeutic genes, enhancing their cancer tissue selectivity and suppressing antiviral protective mechanisms employed by malignant cells (Wang et al., 2022b).
[99] Bridging the gap: From petri dish to patient - Advancements in ... — The landscape of translational research is heavily influenced by regulatory frameworks that aim to ensure safety, efficacy, and ethical compliance in drug development.
[105] Advancements and Obstacles of CRISPR-Cas9 Technology in Translational ... — The system can perform pooled high-throughput genetic screens (Figure 2F).24 In addition, dead Cas9 (dCas9) is a catalytically deactivated Cas9 nuclease (Figure 2C) that can be fused with transcription factors, fluorescent marker proteins, and other functional proteins to regulate gene expression, track target genes, and make unexpected genomic alterations.7 Fusion of a deaminase to dCas9 generated a novel base-editing technology (Figure 2D), resulting in precise and highly efficient C-to-T or G-to-A modifications.25 Moreover, dead guide RNA (dgRNA), with a short 14- to 15-nucleotide (nt) sequence and MS2-binding loops into the backbone, can activate transcription without inducing DSBs (Figure 2E).26 Furthermore, the development of double-nickase Cas9 (Figure 2B) expands the translational application of CRISPR-Cas9 through the generation of a staggered single cleavage in the genome, reducing off-target effects.7 This method minimizes off-target editing and has been used in multiple studies.27
[106] Advancements and Obstacles of CRISPR-Cas9 Technology in Translational ... — The expanding CRISPR-Cas9 technology is an easily accessible, programmable, and precise gene-editing tool with numerous applications, most notably in biomedical research. Together with advancements in genome and transcriptome sequencing in the era of metadata, genomic engineering with CRISPR-Cas9 meets the developmental requirements of precision medicine, and clinical tests using CRISPR-Cas9
[107] In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges — Within less than a decade since its inception, CRISPR-Cas9-based genome editing has been rapidly advanced to human clinical trials in multiple disease areas. Although it is highly anticipated that this revolutionary technology will bring novel
[108] Gene therapy for CNS disorders: modalities, delivery and translational ... — Gene therapy is emerging as a powerful tool to modulate abnormal gene expression, a hallmark of most CNS disorders. The transformative potentials of recently approved gene therapies for the treatment of spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS) and active cerebral adrenoleukodystrophy are encouraging further development of this approach.
[111] A genomic strategy for precision medicine in rare diseases: integrating ... — Given that 80% of rare diseases have a genetic component, delivering genomic information in a timely manner has proven to enhance clinical decision-making, improve patient outcomes, and facilitate personalized treatment strategies, ultimately leading to more effective management of complex diseases . To implement routine genetic testing for all inherited disorders included in the services portfolios of all public Andalusian hospitals, we designed the first version (D1) of an NGS custom designed panel called pRARE (Personalized Rare Diseases Exome), which was subsequently updated twice (D2 and D3, consecutively) with the purpose of improving coverage of the most in-demand groups of pathologies.
[113] Overview of the Regulatory Path to Commercializing a Gene Therapy — Adding to the challenge is the accelerated speed in which many of these products are being brought to market as nearly all gene therapies under development have been assigned one of the FDA’s expedited approval designations. While gene therapies present challenges in every aspect of development, arguably the most challenging is the product testing and characterization that leads to safe and robust manufacturing processes. A successful gene therapy regulatory strategy requires: new product and process validation strategies to accommodate accelerated development timelines, active communication with the FDA and the dedication to pursuing and adopting new technologies to tackle vexing scientific challenges, particularly in the area of product characterization.
[115] Global regulatory progress in delivering on the promise of gene ... — A comparative study of the regulatory submissions for advanced therapy medicinal products (ATMPs) with those for other biologics found that ATMP developers need to comply with more post-approval commitments, which can be a challenge to market performance.6 Furthermore, several non-regulatory issues affect gene therapy access post-approval related to the health technology assessment in some regions, valuation, and payment policies that are beyond the scope of this article. To build on this concept, the WHO recently published a draft working document, which outlines these principles and provides an excellent discussion of principles and considerations.31 While many countries may seek to establish new regulatory frameworks to support gene therapy development, we would recommend a heightened focus on reliance to avoid delays in the introduction of safe and effective products to market.
[131] PDF — W H I T E P A P E R 818-462-8290 | www.sanguinebio.com Overcoming Challenges in Translational Research THE POWER OF BRINGING PATIENTS AND INVESTIGATORS TOGETHER Abstract Translational research emerged as the missing link between basic science and advances in clinical practice meant to markedly improve individual and public health. According to the National Center for Advancing Translational Science, "translation is the process of turning observation in the laboratory, clinic, and community into interventions that improve the health of individuals and the public – from diagnostics and therapeutics to medical procedures and behavioral changes." Stakeholders involved in the process of research translation need to work together to close the gap by increasing collaboration, improving communication, and taking advantage of improvements in the field of biomarkers to promote precision medicine.
[132] Challenges and Drivers of Translational Research - FutureBridge — Translational research is evidence-based research, or disease-targeted research is a collaboration between clinics, research hospitals, governments, academic institutes, and small to large scale industries where different diseases (infectious, acquired, or genetic) are identified, and discoveries are tested in cell culture, animal models, and clinical trials to determine the relevance of novel discoveries in the biological sciences for human health and longevity. It is an iterative process wherein scientific discoveries are integrated into clinical applications and, conversely, clinical observations are used to generate research foci for basic science: the “bench to bedside and back to bench” approach.Translational medicine generates a model of continuous evolution:Due to the introduction of translational research, the knowledge generates since the inception of the concept is far more than actual implementation in clinical practice.
[133] The Continuing Challenges of Translational Research: Clinician ... — In the USA, the National Center for Advancing Translational Sciences (NCATS; http://www.ncats.nih.gov/) was established this year (2012) with its mission to “catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.” This would include dealing with bottlenecks such as regulatory issues in the TR process to make it “more efficient, less expensive and less risky” . These include the building of research units that incorporate multidisciplinary groups which may involve bioinformaticians, statisticians, engineers, basic scientists, and clinicians; increasing expert support in regulatory issues and clinical trial design and conduct; as well as the initiation of forums for interdisciplinary discussion.
[134] Opportunities and challenges in translational science - PMC — However, the area of scientific investigation that seeks to understand the general principles and practices of successful intervention adoption in clinical and public health settings is the field of dissemination and implementation (D&I) science, 68 and is a crucial component of translational science that is only beginning to have the emphasis and support it needs from the research community. Departments of Translational Science will need to have subdisciplines not commonly represented in academic settings (e.g., toxicology, process chemistry, regulatory science, clinical trial design innovation, and implementation science) and have distinct organization and reward structure, incentivizing the team science and multidiscipline collaboration required for successful translation.
[136] Reaping the Benefits of Biomedical Research: Partnerships Required - AAAS — In 2006, NIH launched the CTSA initiative, which thus far has provided 46 AHCs with the funding needed to create homes for clinical and translational science and to train the next generation of investigators to work as interdisciplinary teams (Fig. 1) ().A major goal of the CTSA consortium is to increase the efficiency of translation of scientific discoveries into improved clinical treatments
[137] Interdisciplinary Collaboration Yields Greater Impact — "Interdisciplinary collaboration is important because it opens the door to new ways of thinking and new methods in studying disorders. Interdisciplinary partnerships are powerful as they promote asking new questions and approaching a problem in different ways," reflects Powers. Biostatistics
[143] The Success Story of the Critical Path and Public-Private Partnerships — Maxwell et al.'s "The Role of Public-Private Partnerships in Catalyzing Critical Path," published in Clinical and Translational Science in August 2017, provides a detailed summary of the deliverables of the public-private partnerships, therapeutic areas, and needs addressed by public-private partnerships and critical path opportunities. The
[144] Drug discovery and beyond: the role of public-private partnerships in ... — The partnerships bring together academic and industry expertise with funding from governmental, philanthropic and charitable sources. The Medicines for Malaria Venture, a not-for-profit foundation based in Geneva, aims to develop new antimalarials for developing countries through public-private partnership.
[145] Public-private partnerships as driving forces in the quest for ... — With a budget of € 2 billion, IMI is a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations, aiming at boosting the competitiveness of the pharmaceutical sector across Europe by supporting collaborative networks between the key stakeholders in healthcare .
[148] What Is the Greatest Regulatory Challenge in the Translation of ... — Which leads us to one of the greatest regulatory challenges in translational research: the ability to accurately predict, from preclinical data, the human health risks associated with a new product. This exercise is at best an imperfect science and is particularly challenging for new biomaterials or other novel technologies for which there are
[149] Lost in Translation: Obstacles to Translational Medicine — There are three major obstacles to effective translational medicine. The first is the challenge of translating basic science discoveries into clinical studies. The second hurdle is the translation of clinical studies into medical practice and health care policy . A third obstacle to effective translational medicine is also philosophical.
[153] PDF — the implementation of successful treatments into clinical practice. It includes assessing the real-world impact on patient health and refining the treatment based on clinical feedback and outcomes. While translational medicine holds great promise, it faces several challenges. One major challenge is
[154] Understanding Translational Medicine and Its Impact — As medical researchers and clinical practitioners grapple with an ever-evolving landscape of diseases and patient needs, translational medicine offers a systematic approach to bridging the chasm that often exists between laboratory research and direct patient care. By integrating patients into research, the translational medicine field does not just enhance its relevance in clinical settings but also boosts the likelihood of successful implementation of new therapies. In summary, the real-world applications of translational medicine illustrate its significant impact on cancer treatment and genetic therapies, setting the stage for a future where medical solutions are increasingly tailored to individual patients. Bridge Between Research and Practice: Translational medicine serves as a vital link that allows scientists to navigate their discoveries into real-world applications, impacting patient care directly.
[155] Biotechnology-based therapeutics - ScienceDirect — The field of translational biotechnology is defined as the use of biological materials and employing molecular engineering techniques to form, synthesize, or produce pharmaceutical products that can have a direct impact on improving healthcare (Evens & Kaitin, 2015).
[156] Translational biotechnology: A transition from basic biology to ... — Translational biotechnology has a wide range of applications, ranging from drug discovery and development to biomarker discovery for precision medicine, development of bio-therapeutics, nanomedicine, gene therapy to use of AI for better diagnosis and treatment outcome.
[167] Interdisciplinary Collaboration is key to successful ... - Frontiers — In his Field Grand Challenge for Frontiers in Medicine, Prof. Michel Goldman emphasized the importance of translational medicine to interdisciplinary collaborations. " Translational medicine can be defined as the interdisciplinary science that will cover this continuum, from basic research to preclinical and clinical research, development of
[168] Importance of interdisciplinarity in modern oncology: results of a ... — In addition to its relevance in patient care, interdisciplinary collaboration is also becoming increasingly important in clinical research as well as medical education and resident training in oncology. The initiative “Young Oncologist United” is a joint effort of junior groups of different German medical societies with a clinical or preclinical oncologic interest to improve interdisciplinary cooperation in patient care, research, and training in oncology (Mäurer et al. Interdisciplinary work has become indispensable in oncology and is a substantial guarantor of quality in cancer care practices (Tremblay et al. As the population is aging, an increasing demand of interdisciplinary care is expected due to a growing number of oncologic patients (Sung et al.
[169] Interdisciplinary dissemination and implementation research to advance ... — Health sciences researchers in multiple disciplines, including psychology, health services, epidemiology, social work, and medicine, are gradually recognizing the importance of using TDII methodologies to translate evidence into practice ; however, researchers face significant barriers to working together and engaging in TDII research. Communication, taxonomy, and language Structural content of communication across disciplines, which lacks congruence to develop coherent principles and paradigms Develop consolidated frameworks for a variety of DII research areas by engaging different disciplines in the process of unifying conceptual and methodological approaches Exploring National Institutes of Health resources on building interdisciplinary teams for potential solutions such as meetings with researchers from different departments in order to consolidate information under a unifying framework
[170] Translational Medicine: Insights from Interdisciplinary Graduate ... — Translational Medicine: Insights from Interdisciplinary Graduate Research Training - ScienceDirect Translational Medicine: Insights from Interdisciplinary Graduate Research Training Biomedical research faces a scarcity of scientists able to work effectively at the interface of diverse scientific disciplines; we reflect on our experience over ten years of interdisciplinary training through our Masters of Research in Translational Medicine, preparing a new generation of researchers for postgenomic interdisciplinary medical research. This program was supported in part by a Medical Research Council UK Advanced Course Masters Training grant (MR/J016004/1). Cookies are used by this site. These cookies may be set through our site by our advertising partners.
[171] Interdisciplinary Collaboration Yields Greater Impact — Over the course of her Pilot Project funded by Women’s Health Research at Yale, Carolyn Fredericks, MD, assistant professor of neurology, forged interdisciplinary partnerships to propel her research forward. An interdisciplinary research partnership is one that integrates multiple scientific and other academic disciplines, areas of expertise, or fields of study, to address a question that is designed to respond to a health issue. At Women’s Health Research at Yale, building interdisciplinary partnerships is one of our initiatives, and encouraging and often facilitating this process in our pilot funding is an ideal way to bring disciplines together. Women’s Health Research at Yale’s interdisciplinary research partnerships bring together Yale faculty from a variety of fields to investigate health conditions specifically affecting women, more prevalent in women, or affecting women differently than men.
[172] Translational health policy: towards an integration of academia and ... — 'Bench to bedside' translational research is now an established concept and involves close collaboration of researchers and clinicians in designing and conducting clinical trials and testing novel therapeutic methods in fields such as oncology. 1,2 Although translational research was initially confined to medical applications, other
[173] The Case for Understanding Interdisciplinary Relationships in Health ... — Another example of interdisciplinary collaboration is accountable care organizations that mandate interdisciplinary relationships in the form of teams consisting of a primary care physician, nursing staff, and specialists who care for patients.10,11 This kind of health care collaboration has been suggested as an effective option for lowering the cost of patient care and improving patient outcomes.10 Kaufman et al reviewed 42 articles that assessed the effect of accountable care organizations on health care utilization, processes of care, and outcomes.12 The articles included in the review were 24 Medicare studies, 5 Medicaid studies, and 13 private payer studies.
[174] New Orientation of Interdisciplinarity in Medicine: Engineering ... — New orientation of Interdisciplinarity in medicine: Engineering Medicine - ScienceDirect New orientation of Interdisciplinarity in medicine: Engineering Medicine Over time, the field of medicine has transitioned from enigmatic witch doctors and herbal remedies to a sophisticated realm of contemporary medicine that includes fundamental medical and health sciences, clinical medicine, and public health. Nevertheless, the present phase of medical advancement encounters significant challenges, particularly in effectively translating basic research findings into practical applications in clinical and public health settings. This collaborative effort has created a new interdisciplinary field: engineering medicine (EngMed), which focuses on addressing clinical and public health needs by integrating various scientific disciplines. Engineering medicine No articles found. For all open access content, the Creative Commons licensing terms apply.
[175] Interdisciplinary research: shaping the healthcare of the future — The issue of protecting clinician time for research, including research which involves cross-disciplinary collaborations, is widely recognised and solutions are being proposed.16,17 Interdisciplinary collaborations are often best supported by a programme of engagement planned and supported by established research platforms, including those funded by the National Institute for Health Research (NIHR); for example, in Leeds, the NIHR Surgical MedTech Cooperative drives collaborations at scale between clinicians, physicists, engineers, industry and patients aimed at addressing unmet needs (Fig 2).18 Further upstream in the research pipeline, the Bragg Centre for Advanced Materials Research has a regular programme of events which promote novel interdisciplinary approaches to key clinical topics, such as drug targeting and delivery.19
[185] PDF — By bridging the gap between basic research and clinical application, translational medicine plays a crucial role in expediting the adoption of innovative approaches and technologies that have the potential to revolutionize healthcare.
[186] PDF — Key components of translational science Translational science research encompasses diverse methodologies, interdisciplinary collaborations and infrastructural support systems essential for driving scientific discovery and innovation. Key components include interdisciplinary research teams comprising basic scientists, clinicians, epidemiologists and biostatisticians, who collaborate to address
[187] Translational research and key aspects to make it successful — Translational research and key aspects to make it successful | Translational Medicine Communications | Full Text Translational research refers to the translation of scientific discoveries into practical applications that can benefit patients and the wider society. So, in a way translational research aims to improve human health through the integration of basic science and clinical practice. In translational research, leadership can include overseeing a team consisting of healthcare professionals. Project management is essential for translational research and it requires collaboration and mainly coordination between many departments. Communication is the key in the translational research as it improves everyone's awareness and keeps them informed about the situation’s arounds the projects. People, organizational, and leadership factors impacting informatics support for clinical and translational research. Translational research
[196] PDF — exhibit these interpersonal skills (e.g., communication, conflict management, and leadership) to foster collaboration and innovation (Teng et al., 2019). Consequently, by fostering the growth of these critical skills, the program effectively positions its graduate students for success upon finishing their educational degrees.
[197] Designing for Interdisciplinarity in Higher Education: Considerations ... — Embedding interdisciplinarity into a higher educational curriculum allows students to develop competence in synthesizing and applying knowledge and skills from across multiple disciplines to address problems and find solutions that would not be possible if only a single disciplinary lens is used. This review of the literature focused on reviewing the state of interdisciplinarity, benefits and
[207] Translational medical research: present and future - PMC — Translational medicine is one of the oldest medical practices during the evolution of human society, although its importance has just been increasingly recognized by more and more medical investigators and practicing physicians since the time entered the 21 st century.. Translational research incorporates some of the oldest knowledge that the human race has gathered, from healing practices of
[208] Translational medicine 101: The future of personalized care — Researchers were able to design, test, and begin distributing these vaccines in under a year, thanks to decades of prior research into mRNA vaccine technology, showcasing the rapid capabilities of translational approaches. The future of healthcare. Looking ahead, the implications of translational medicine for the future of healthcare are vast.
[209] The Continuing Challenges of Translational Research: Clinician ... — In the USA, the National Center for Advancing Translational Sciences (NCATS; http://www.ncats.nih.gov/) was established this year (2012) with its mission to “catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.” This would include dealing with bottlenecks such as regulatory issues in the TR process to make it “more efficient, less expensive and less risky” . These include the building of research units that incorporate multidisciplinary groups which may involve bioinformaticians, statisticians, engineers, basic scientists, and clinicians; increasing expert support in regulatory issues and clinical trial design and conduct; as well as the initiation of forums for interdisciplinary discussion.
[210] Challenges and Drivers of Translational Research - FutureBridge — Translational research is evidence-based research, or disease-targeted research is a collaboration between clinics, research hospitals, governments, academic institutes, and small to large scale industries where different diseases (infectious, acquired, or genetic) are identified, and discoveries are tested in cell culture, animal models, and clinical trials to determine the relevance of novel discoveries in the biological sciences for human health and longevity. It is an iterative process wherein scientific discoveries are integrated into clinical applications and, conversely, clinical observations are used to generate research foci for basic science: the “bench to bedside and back to bench” approach.Translational medicine generates a model of continuous evolution:Due to the introduction of translational research, the knowledge generates since the inception of the concept is far more than actual implementation in clinical practice.
[212] Involving lived experience experts in translational research — Patient and public involvement refers to integrating subjective experiential knowledge about the medical and psychosocial effects of diseases and treatments into health research. This approach
[214] Patient perspectives - ScienceDirect — Integration of the patient, and therefore their perceptions, into the clinical research process starting with research question development and continuing through the dissemination of research evidence has numerous benefits to the researcher, the research, and to the patient.
[216] Understanding Translational Medicine and Its Impact — As medical researchers and clinical practitioners grapple with an ever-evolving landscape of diseases and patient needs, translational medicine offers a systematic approach to bridging the chasm that often exists between laboratory research and direct patient care. By integrating patients into research, the translational medicine field does not just enhance its relevance in clinical settings but also boosts the likelihood of successful implementation of new therapies. In summary, the real-world applications of translational medicine illustrate its significant impact on cancer treatment and genetic therapies, setting the stage for a future where medical solutions are increasingly tailored to individual patients. Bridge Between Research and Practice: Translational medicine serves as a vital link that allows scientists to navigate their discoveries into real-world applications, impacting patient care directly.
[217] Using patient feedback to drive quality improvement in hospitals: a ... — Establishing a formal communication process with patients may be considered the first stage of patient involvement because obtaining feedback can provide the information needed to promote improvements in internal processes and support strategic planning.8 According to Hernan et al,9 implementing a patient feedback system involves the collection of feedback from patients through research and the analysis of the results by a designated team that later reports back to the health team for inclusion in the action plan. In addition to the interviews, we conducted a document analysis that included reviewing patient feedback forms, data consolidation reports, action plans, process standards and protocols for implementing improvements, as well as hospital secondary data, such as the institutional websites, social networks and the service site for registering consumer complaints.
[226] Bridging the gap: From petri dish to patient - ScienceDirect — The landscape of translational research is heavily influenced by regulatory frameworks that aim to ensure safety, efficacy, and ethical compliance in drug development. Recent changes in these regulatory frameworks have been designed to better accommodate and encourage innovations in translational research.
[227] Moving at the speed of science: Regulatory flexibility for unmet ... — European and Asian regulatory agencies are also exploring new ways to get new medicines to patients faster while maintaining a robust regulatory review. For example, the EMA is using adaptive pathways, a scientific concept for medicine development and data generation that allows for early and progressive patient access to a medicine using the
[228] Regulatory Trends in Pharma Manufacturing: Key Changes to Watch in 2025 — Major regulatory changes in 2025 In January 2025, the US FDA published a draft regulatory guidance entitled "The Considerations for Use of Artificial Intelligence to Support Regulatory Decision
[229] Tribulations and future opportunities for artificial intelligence in ... — This article reviews AI applications in drug development and clinical practice, making healthcare more sustainable, and highlights concerns and limitations in applying AI. The utilization of AI technologies has become increasingly significant in accelerating various areas of biomedical research, including drug discovery and development, image-based disease diagnosis, and the analysis of large datasets, consequently enhancing decision-making processes across a wide range of fields and disciplines such as drug discovery, molecular biology, imaging, pathology, toxicology, and clinical medicine. The words shown in the left column of the table have increased significantly since the first use of AI in any of the selected fields of medical research, including drug discovery, development, medicinal chemistry, cancer research, PM, etc.
[230] Building Better Medicine: Translational Justice and the Quest for ... — A reinvigorated health economics discourse has echoed our call for translational justice: i.e., innovating and building health data infrastructure that measures cost and access in ways that reflect the perspectives of patients and families, rather than treating patient satisfaction and cost as distinct, unrelated phenomena (Smith et al
[231] Balancing Innovation and Access: Patent Challenges Tip the Scales — Congress originally intended to strike a balance between two conflicting, but related, policy objectives: ensuring timely, affordable access to drugs, by allowing for expedited FDA approval of generic drugs, and encouraging drug innovation, by restoring some years of patent protection that are lost by firms during the average 1 to 2 years spent
[232] Toward Equitable Innovation in Health and Medicine: A Framework. — To achieve the vision described in the prior chapters, the committee advances six recommendations reflecting major areas in which efforts are needed to reorient the system of emerging science, technology, and innovation in health and medicine toward one that is equitable and responsive to the needs of a broader range of the system's users, and more capable of recognizing and addressing
[233] Toward Equitable Innovation in Health and Medicine — National Academy of Medicine; National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine. The National Academies of Sciences, Engineering, and Medicine, in collaboration with the National Academy of Medicine, established the Committee on Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine to provide leadership and engage broad communities in developing a framework for aligning the development and use of transformative technologies with ethical and equitable principles. National Academy of Medicine; National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Creating a Framework for Emerging Science, Technology, and Innovation in Health and Medicine.
[234] Toward Equitable Innovation in Health and Medicine: A Framework. — The prior chapters describe various ways in which the innovation life cycle can lead to anticipated and unanticipated patterns of inequity. Those chapters also establish an ethical imperative for improved governance of innovation in health and medicine and make a business case for moving toward an innovation framework that is more aligned with principles encompassing equity. This chapter